TY - JOUR
T1 - Technetium-99m-labeled red blood cell imaging
AU - Front, Dov
AU - Israel, Ora
AU - Groshar, David
AU - Weininger, Jolie
N1 - Funding Information:
From the Department of Nuclear Medicine, Rambam Medical Center, and Technion Faculty of Medicine, Haifa, and Soreq Nuclear Research Center, Yavne, Israel. Dr. Groshar is the recipient of a fellowship from the International Atomic Energy Agency (Vienna) supported by the Brazilian Nuclear Energy Commission and the Atomic Energy Commission of lsrael. Address reprint requests to Dov Front, M.D., Ph.D., Department of Nuclear Medicine, Rambam Medical Center, Haifa 35254, Israel. 9 1984 by Grune & Stratton, Inc. 0001-2998/84/1403-0006505.00/0
PY - 1984/7
Y1 - 1984/7
N2 - Red blood cells labeled with 99mTc constitute a suitable intravascular agent for imaging of vascular abnormalities. Hemangiomas are characterized by low perfusion and a high blood pool. This "perfusion blood-pool mismatch," not encountered in other lesions, may help in the specific diagnosis of this tumor. This is particularly so in cavernous hemangiomas of the liver where three-phase 99mTc-labeled red blood cell scintigraphy should precede liver biopsy. Red cell scintigraphy also is useful for estabishing the vascular nature of hemangiomas of the head and neck and the skin and for diagnosis of venous occlusion. Hear-damaged red blood cells provide a specific spleen imaging agent. This should be used when patients with suspected splenic pathology have equivocal colloid scintigraphy.
AB - Red blood cells labeled with 99mTc constitute a suitable intravascular agent for imaging of vascular abnormalities. Hemangiomas are characterized by low perfusion and a high blood pool. This "perfusion blood-pool mismatch," not encountered in other lesions, may help in the specific diagnosis of this tumor. This is particularly so in cavernous hemangiomas of the liver where three-phase 99mTc-labeled red blood cell scintigraphy should precede liver biopsy. Red cell scintigraphy also is useful for estabishing the vascular nature of hemangiomas of the head and neck and the skin and for diagnosis of venous occlusion. Hear-damaged red blood cells provide a specific spleen imaging agent. This should be used when patients with suspected splenic pathology have equivocal colloid scintigraphy.
UR - http://www.scopus.com/inward/record.url?scp=0021457377&partnerID=8YFLogxK
U2 - 10.1016/S0001-2998(84)80017-3
DO - 10.1016/S0001-2998(84)80017-3
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 6089353
AN - SCOPUS:0021457377
SN - 0001-2998
VL - 14
SP - 226
EP - 250
JO - Seminars in Nuclear Medicine
JF - Seminars in Nuclear Medicine
IS - 3
ER -
